Genetic control of N-glycosylation of human blood plasma proteins

Glycosylation is an important protein modification, which influences the physical and chemical properties as well as biological function of these proteins. Large-scale population studies have shown that the levels of various plasma protein N-glycans are associated with many multifactorial human dise...

Full description

Saved in:
Bibliographic Details
Main Authors: S. Zh. Sharapov, A. N. Timoshchuk, Y. S. Aulchenko
Format: Article
Language:English
Published: Siberian Branch of the Russian Academy of Sciences, Federal Research Center Institute of Cytology and Genetics, The Vavilov Society of Geneticists and Breeders 2023-06-01
Series:Вавиловский журнал генетики и селекции
Subjects:
Online Access:https://vavilov.elpub.ru/jour/article/view/3734
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832575024566894592
author S. Zh. Sharapov
A. N. Timoshchuk
Y. S. Aulchenko
author_facet S. Zh. Sharapov
A. N. Timoshchuk
Y. S. Aulchenko
author_sort S. Zh. Sharapov
collection DOAJ
description Glycosylation is an important protein modification, which influences the physical and chemical properties as well as biological function of these proteins. Large-scale population studies have shown that the levels of various plasma protein N-glycans are associated with many multifactorial human diseases. Observed associations between protein glycosylation levels and human diseases have led to the conclusion that N-glycans can be considered a potential source of biomarkers and therapeutic targets. Although biochemical pathways of glycosylation are well studied, the understanding of the mechanisms underlying general and tissue-specific regulation of these biochemical reactions in vivo is limited. This complicates both the interpretation of the observed associations between protein glycosylation levels and human diseases, and the development of glycan-based biomarkers and therapeutics. By the beginning of the 2010s, high-throughput methods of N-glycome profiling had become available, allowing research into the genetic control of N-glycosylation using quantitative genetics methods, including genome-wide association studies (GWAS). Application of these methods has made it possible to find previously unknown regulators of N-glycosylation and expanded the understanding of the role of N-glycans in the control of multifactorial diseases and human complex traits. The present review considers the current knowledge of the genetic control of variability in the levels of N-glycosylation of plasma proteins in human populations. It briefly describes the most popular physical-chemical methods of N-glycome profiling and the databases that contain genes involved in the biosynthesis of N-glycans. It also reviews the results of studies of environmental and genetic factors contributing to the variability of N-glycans as well as the mapping results of the genomic loci of N-glycans by GWAS. The results of functional in vitro and in silico studies are described. The review summarizes the current progress in human glycogenomics and suggests possible directions for further research.
format Article
id doaj-art-7b3f93874eca4dee81c2af49a109d421
institution Kabale University
issn 2500-3259
language English
publishDate 2023-06-01
publisher Siberian Branch of the Russian Academy of Sciences, Federal Research Center Institute of Cytology and Genetics, The Vavilov Society of Geneticists and Breeders
record_format Article
series Вавиловский журнал генетики и селекции
spelling doaj-art-7b3f93874eca4dee81c2af49a109d4212025-02-01T09:58:12ZengSiberian Branch of the Russian Academy of Sciences, Federal Research Center Institute of Cytology and Genetics, The Vavilov Society of Geneticists and BreedersВавиловский журнал генетики и селекции2500-32592023-06-0127322423910.18699/VJGB-23-291348Genetic control of N-glycosylation of human blood plasma proteinsS. Zh. Sharapov0A. N. Timoshchuk1Y. S. Aulchenko2MSU Institute for Artificial Intelligence, Lomonosov Moscow State UniversityMSU Institute for Artificial Intelligence, Lomonosov Moscow State UniversityMSU Institute for Artificial Intelligence, Lomonosov Moscow State University; Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of SciencesGlycosylation is an important protein modification, which influences the physical and chemical properties as well as biological function of these proteins. Large-scale population studies have shown that the levels of various plasma protein N-glycans are associated with many multifactorial human diseases. Observed associations between protein glycosylation levels and human diseases have led to the conclusion that N-glycans can be considered a potential source of biomarkers and therapeutic targets. Although biochemical pathways of glycosylation are well studied, the understanding of the mechanisms underlying general and tissue-specific regulation of these biochemical reactions in vivo is limited. This complicates both the interpretation of the observed associations between protein glycosylation levels and human diseases, and the development of glycan-based biomarkers and therapeutics. By the beginning of the 2010s, high-throughput methods of N-glycome profiling had become available, allowing research into the genetic control of N-glycosylation using quantitative genetics methods, including genome-wide association studies (GWAS). Application of these methods has made it possible to find previously unknown regulators of N-glycosylation and expanded the understanding of the role of N-glycans in the control of multifactorial diseases and human complex traits. The present review considers the current knowledge of the genetic control of variability in the levels of N-glycosylation of plasma proteins in human populations. It briefly describes the most popular physical-chemical methods of N-glycome profiling and the databases that contain genes involved in the biosynthesis of N-glycans. It also reviews the results of studies of environmental and genetic factors contributing to the variability of N-glycans as well as the mapping results of the genomic loci of N-glycans by GWAS. The results of functional in vitro and in silico studies are described. The review summarizes the current progress in human glycogenomics and suggests possible directions for further research.https://vavilov.elpub.ru/jour/article/view/3734glycomeglycansn-glycosylationgeneticsgwas
spellingShingle S. Zh. Sharapov
A. N. Timoshchuk
Y. S. Aulchenko
Genetic control of N-glycosylation of human blood plasma proteins
Вавиловский журнал генетики и селекции
glycome
glycans
n-glycosylation
genetics
gwas
title Genetic control of N-glycosylation of human blood plasma proteins
title_full Genetic control of N-glycosylation of human blood plasma proteins
title_fullStr Genetic control of N-glycosylation of human blood plasma proteins
title_full_unstemmed Genetic control of N-glycosylation of human blood plasma proteins
title_short Genetic control of N-glycosylation of human blood plasma proteins
title_sort genetic control of n glycosylation of human blood plasma proteins
topic glycome
glycans
n-glycosylation
genetics
gwas
url https://vavilov.elpub.ru/jour/article/view/3734
work_keys_str_mv AT szhsharapov geneticcontrolofnglycosylationofhumanbloodplasmaproteins
AT antimoshchuk geneticcontrolofnglycosylationofhumanbloodplasmaproteins
AT ysaulchenko geneticcontrolofnglycosylationofhumanbloodplasmaproteins